804052950	804052950	CD	B-NP	O
|	|	NN	I-NP	O
AH	AH	NN	I-NP	O
|	|	NN	I-NP	O
18303651	18303651	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6857225	6857225	CD	B-NP	O
|	|	CC	I-NP	O
10/23/2006	10/23/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Chest	Chest	NNP	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
2/2	2/2	CD	I-NP	I-protein
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/6/2006	1/6/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/3/2006	8/3/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
BUCHAMAN	BUCHAMAN	NN	B-NP	O
,	,	,	O	O
ROY	ROY	NN	B-NP	O
158-84-12-4	158-84-12-4	CD	I-NP	O
Woodca	Woodca	NNP	I-NP	O
Road	Road	NNP	I-NP	O
`	`	``	I-NP	O
sfi	sfi	NN	I-NP	O
Ave	Ave	NNP	I-NP	O
,	,	,	O	O
Seat	Seat	NNP	B-NP	O
E	E	NNP	I-NP	O
,	,	,	O	O
Michigan	Michigan	NNP	B-NP	O
65984	65984	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
10/16/06	10/16/06	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
REDDINGTON	REDDINGTON	NNP	B-NP	O
,	,	,	O	O
LUCIUS	LUCIUS	NNP	B-NP	O
S.	S.	NNP	I-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
PLAVIX	PLAVIX	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Tomorrow	Tomorrow	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
6/16	6/16	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
ASA	ASA	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
GLYBURIDE	GLYBURIDE	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/17/06	6/17/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
GLYBURIDE	GLYBURIDE	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	O
836938200	836938200	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Sulfa	Sulfa	NNP	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
needs	need	NNS	B-NP	O
and	and	CC	O	O
tolerates	tolerate	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	B-DNA
LEVOXYL	LEVOXYL	NN	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	I-DNA
SODIUM	SODIUM	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
250	250	CD	I-NP	I-DNA
MCG	MCG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
TOPROL	TOPROL	NNP	I-NP	I-DNA
XL	XL	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
METOPROLOL	METOPROLOL	NNP	I-NP	I-DNA
SUCCINATE	SUCCINATE	NNP	I-NP	I-DNA
EXTENDED	EXTENDED	NNP	I-NP	I-DNA
RELEASE	RELEASE	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
75	75	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
Starting	Starting	NNP	I-NP	I-DNA
Today	Today	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
6/16	6/16	CD	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
SL	SL	NN	I-NP	I-protein
q5min	q5min	NN	I-NP	I-protein
x	x	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-DNA
<	<	SYM	O	I-DNA
100	100	CD	B-NP	I-DNA
ZOCOR	ZOCOR	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-DNA
-RRB-	-RRB-	,	O	I-DNA
40	40	CD	B-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

ISORDIL	ISORDIL	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
DINITRATE	DINITRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
FLOMAX	FLOMAX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
TAMSULOSIN	TAMSULOSIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/16/06	10/16/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
FLOMAX	FLOMAX	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
022848242	022848242	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Sulfa	Sulfa	NNP	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
DR.	DR.	NNP	B-NP	O
TOH	TOH	NN	I-NP	O
,	,	,	O	O
ISIAH	ISIAH	NN	B-NP	B-protein
,	,	,	O	O
SCH	SCH	NN	B-NP	O
CARDIOLOGY	CARDIOLOGY	NN	I-NP	O
8/22	8/22	CD	I-NP	O
@	@	NN	I-NP	O
1pm	1pm	NN	I-NP	O
,	,	,	O	O
DR.	DR.	NNP	B-NP	O
BELKOWSKI	BELKOWSKI	NNP	I-NP	O
,	,	,	O	O
,	,	,	O	O
PCP	PCP	NN	B-NP	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
October	October	NNP	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
AM	AM	VBP	B-VP	O
,	,	JJ	B-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
Sulfa	Sulfa	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Chest	Chest	NNP	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Chest	Chest	NNP	I-NP	O
pain	pain	NN	I-NP	O
2/2	2/2	CD	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
aortic	aortic	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
aortic	aortic	JJ	I-NP	B-protein
stenosis	stenosis	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
diabetes	diabete	VBZ	B-VP	O
-LRB-	-LRB-	NN	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
depression	depression	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
depression	depression	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
prostate	prostate	NN	I-NP	O
cancer	cancer	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
prostate	prostate	NN	I-NP	O
cancer	cancer	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6/13/2006	6/13/2006	CD	I-NP	O
LHC	LHC	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Right	Right	RB	B-NP	O
dominant	dominant	JJ	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
LM	LM	NN	I-NP	B-protein
lesions	lesion	NNS	I-NP	I-protein
3	3	CD	B-NP	I-protein
.	.	.	O	O

LAD	LAD	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	I-NP	O
proximal	proximal	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
discrete	discrete	JJ	I-NP	O
1005	1005	CD	I-NP	O
lesion	lesion	NN	I-NP	O
after	after	IN	B-PP	O
D1	D1	NN	B-NP	O
origin	origin	NN	I-NP	O
.	.	.	O	O

D1	D1	NN	B-NP	O
widely	widely	RB	I-NP	O
patent	patent	NN	I-NP	O
including	include	VBG	B-PP	O
prior	prior	JJ	B-NP	O
stent	stent	NN	I-NP	O
.	.	.	O	O

LAD	LAD	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
mid	mid	JJ	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
a	a	DT	B-NP	O
discrete	discrete	JJ	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Cx	Cx	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	I-NP	O
proximal	proximal	JJ	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
discrete	discrete	JJ	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

RCA	RCA	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	I-NP	O
proximal	proximal	JJ	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
discrete	discrete	JJ	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

LIMA	LIMA	NN	B-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
patent	patent	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
distal	distal	JJ	B-NP	O
LAD	LAD	NN	I-NP	O
occluded	occlude	VBD	B-VP	O
-LRB-	-LRB-	NN	B-NP	B-protein
small	small	JJ	I-NP	I-protein
vessel	vessel	NN	I-NP	I-protein
disease	disease	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
Marg2	Marg2	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
distal	distal	JJ	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
a	a	DT	B-NP	O
tubular	tubular	JJ	I-NP	B-protein
70	70	CD	I-NP	I-protein
%	%	NN	I-NP	I-protein
lesion	lesion	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
Right	Right	NN	B-NP	O
PDA	PDA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ostial	ostial	JJ	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
a	a	DT	B-NP	O
discrete	discrete	JJ	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Collateral	Collateral	JJ	B-NP	O
flow	flow	NN	I-NP	O
from	from	IN	B-PP	O
Marg2	Marg2	NN	B-NP	B-protein
to	to	TO	B-PP	O
right	right	JJ	B-NP	B-protein
PDA	PDA	NN	I-NP	I-protein
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

PCI	PCI	NN	B-NP	O
:	:	:	O	O
SVG	SVG	NN	B-NP	O
TO	TO	TO	B-VP	O
MARG2	MARG2	NN	I-VP	B-protein
TO	TO	TO	B-PP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
W	W	NN	I-NP	O
/	/	SYM	B-VP	O
A	A	NN	B-NP	O
3.5	3.5	CD	I-NP	O
mm	mm	NN	I-NP	O
CYPHER	CYPHER	NN	I-NP	O
POSTDILATED	POSTDILATED	VBD	B-VP	O
TO	TO	TO	B-PP	O
4.0	4.0	CD	B-NP	O
mm	mm	NN	I-NP	O
W	W	NN	I-NP	O
/	/	SYM	B-NP	O
GOOD	GOOD	NN	I-NP	O
RESULT	RESULT	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
IDENTIFICATION	IDENTIFICATION	NN	B-NP	O
:	:	:	O	O
81M	81M	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
h/o	h/o	NN	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
2-vessel	2-vessel	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
redo	redo	NN	B-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
PCIx4	PCIx4	NN	B-NP	B-protein
admitted	admit	VBD	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
2	2	CD	I-NP	O
month	month	NN	I-NP	O
h/o	h/o	NN	I-NP	O
increasingly	increasingly	RB	B-NP	O
frequent	frequent	JJ	I-NP	O
exertional	exertional	JJ	I-NP	O
CP	CP	NN	I-NP	B-DNA
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Stathes	Stathes	NNP	I-NP	O
reports	report	VBZ	B-VP	O
increasingly	increasingly	RB	B-NP	O
frequent	frequent	JJ	I-NP	O
exertional	exertional	JJ	I-NP	O
CP	CP	NN	I-NP	B-DNA
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
2	2	CD	I-NP	O
months	month	NNS	I-NP	O
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
occurring	occur	VBG	I-VP	O
about	about	RB	B-NP	O
twice	twice	RB	I-NP	O
daily	daily	RB	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	B-protein
2	2	CD	I-NP	I-protein
weeks	week	NNS	I-NP	I-protein
.	.	.	O	O

Described	Describe	VBN	B-VP	O
as	as	IN	B-PP	O
sub-sternal	sub-sternal	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
5/10	5/10	CD	B-NP	O
,	,	,	O	O
w/o	w/o	NN	B-NP	O
radiation	radiation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
relieved	relieve	VBN	B-VP	O
within	within	IN	B-PP	O
10-15	10-15	CD	B-NP	O
minutes	minute	NNS	I-NP	O
of	of	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

Now	Now	RB	B-ADVP	O
occurring	occur	VBG	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	I-NP	O
walking	walking	NN	I-NP	O
2-3	2-3	NN	I-NP	O
blocks	block	VBZ	B-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
pace	pace	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
describes	describe	VBZ	B-VP	O
near	near	IN	B-PP	O
daily	daily	JJ	B-NP	O
CP	CP	NN	I-NP	B-DNA
upon	upon	IN	B-PP	O
waking	wake	VBG	B-VP	O
up	up	RP	B-PRT	O
,	,	,	O	O
relieved	relieve	VBN	B-VP	O
within	within	IN	B-PP	O
30	30	CD	B-NP	O
minutes	minute	NNS	I-NP	O
of	of	IN	B-PP	O
resting	rest	VBG	B-NP	O
.	.	.	O	O

Has	Have	VBD	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
sl	sl	NN	B-NP	O
.	.	.	O	O

nitro	nitro	FW	B-NP	O
.	.	.	O	O

CP	CP	NN	B-NP	B-DNA
not	not	RB	B-VP	O
associated	associate	VBN	I-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-VP	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
nausea/vomiting	nausea/vomiting	NN	B-NP	O
,	,	,	O	O
nor	nor	CC	O	O
diaphoresis	diaphoresis	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
PND	PND	NN	I-NP	B-protein
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
nor	nor	CC	O	O
LE	LE	NN	B-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
MRI	MRI	NN	I-NP	O
,	,	,	O	O
myocardial	myocardial	JJ	B-NP	O
perfusion	perfusion	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
adenosine	adenosine	NN	I-NP	O
stress	stress	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
abnormal	abnormal	JJ	B-ADJP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
cath	cath	NN	I-NP	O
.	.	.	O	O

was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
he	he	PRP	B-NP	O
sought	seek	VBD	B-VP	O
a	a	DT	B-NP	O
2nd	2nd	JJ	I-NP	O
opinion	opinion	NN	I-NP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
MHMC	MHMC	NN	I-NP	B-protein
in	in	IN	B-PP	O
A	A	NN	B-NP	O
On	On	IN	B-PP	O
arrival	arrival	NN	B-NP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
MMH	MMH	NN	I-NP	B-protein
on	on	IN	B-PP	O
10/27	10/27	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
diaphoretic	diaphoretic	JJ	B-NP	O
and	and	CC	I-NP	O
orthostatic	orthostatic	JJ	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
an	an	DT	B-NP	O
SBP	SBP	NN	I-NP	B-protein
as	as	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
as	as	IN	B-PP	O
70	70	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
volume-depleted	volume-depleted	JJ	B-ADJP	O
and	and	CC	O	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
and	and	CC	O	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
negativex3	negativex3	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
to	to	TO	I-VP	O
proceed	proceed	VB	I-VP	O
to	to	TO	B-PP	O
cardiac	cardiac	JJ	B-NP	O
cath	cath	NN	I-NP	O
.	.	.	O	O

at	at	IN	B-PP	O
AAMHC	AAMHC	NN	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
chose	choose	VBD	B-VP	O
to	to	TO	I-VP	O
come	come	VB	I-VP	O
to	to	TO	B-PP	O
KNMC	KNMC	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
b/c	b/c	NN	I-NP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
care	care	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
here	here	RB	B-ADVP	O
-RRB-	-RRB-	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
on	on	IN	B-PP	O
10/9	10/9	CD	B-NP	O
for	for	IN	B-PP	O
elective	elective	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
cath	cath	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
nor	nor	CC	O	O
SOB	SOB	NN	O	B-protein
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
2-vessel	2-vessel	NN	I-NP	O
CABG	CABG	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
1995	1995	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
SVG	SVG	NN	I-NP	O
to	to	TO	B-PP	O
Diag2	Diag2	NN	B-NP	B-protein
and	and	CC	I-NP	O
OM1	OM1	NN	I-NP	B-protein
;	;	:	O	O
subsequent	subsequent	JJ	B-NP	O
re-do	re-do	JJ	I-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
;	;	:	O	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
PCIx4	PCIx4	NN	B-NP	B-protein
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
22	22	CD	B-NP	O
of	of	IN	B-PP	O
June	June	NNP	B-NP	O
,	,	,	O	O
Diag1	Diag1	NN	B-NP	B-protein
rotablated	rotablate	VBN	B-VP	O
;	;	:	O	O
30	30	CD	B-NP	O
of	of	IN	B-PP	O
March	March	NNP	B-NP	O
Diag1	Diag1	NNP	I-NP	O
stented	stente	VBD	B-VP	O
;	;	:	O	O
15	15	CD	B-NP	O
of	of	IN	B-PP	O
May	May	NNP	B-NP	O
LAD	LAD	NNP	I-NP	O
beta-radiated	beta-radiate	VBD	B-VP	O
;	;	:	O	O
and	and	CC	O	O
15	15	CD	B-NP	O
of	of	IN	B-PP	O
May	May	NNP	B-NP	O
LCx	LCx	NNP	I-NP	O
ballooned	balloon	VBD	B-VP	O
2	2	CD	B-NP	O
.	.	.	O	O

Aortic	Aortic	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
previous	previous	JJ	B-NP	O
AVA	AVA	NN	I-NP	O
0.8	0.8	CD	B-NP	O
centimeters	centimeter	NNS	I-NP	O
squared	squared	JJ	B-NP	O
,	,	,	I-NP	O
peak	peak	JJ	I-NP	O
gradient	gradient	NN	I-NP	O
72	72	CD	I-NP	O
mmHg	mmHg	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
mean	mean	JJ	B-NP	O
gradient	gradient	NN	I-NP	O
46	46	CD	I-NP	O
mmHg	mmHg	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
AVR	AVR	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
a	a	DT	B-NP	O
Carpentier-Edwards	Carpentier-Edwards	JJ	I-NP	O
23	23	CD	I-NP	O
mm	mm	NN	I-NP	O
pericardial	pericardial	JJ	I-NP	O
valve	valve	NN	I-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

HTN	HTN	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Type	Type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

GERD	GERD	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Prostate	Prostate	NN	B-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
XRT	XRT	NN	I-NP	O
and	and	CC	O	O
now	now	RB	B-ADVP	O
on	on	IN	B-PP	O
hormonal	hormonal	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Hypothyroidism	Hypothyroidism	NN	B-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Dyslipidemia	Dyslipidemia	NN	B-NP	B-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Benign	Benign	JJ	B-NP	O
prostatic	prostatic	JJ	I-NP	O
hyperplasia	hyperplasia	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Depression	Depression	NN	B-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

H/o	H/o	NNP	B-NP	O
incarcerated	incarcerate	VBD	B-VP	O
inguinal	inguinal	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
s/p	s/p	NN	I-NP	O
repair	repair	NN	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	RB	B-ADVP	O
qdaily	qdaily	RB	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Glyburide	Glyburide	NN	B-NP	B-protein
2.5	2.5	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
po	po	RB	B-ADVP	I-protein
qdaily	qdaily	RB	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Imdur	Imdur	IN	B-PP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
po	po	NN	I-NP	I-protein
bid	bid	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
recently	recently	RB	B-VP	O
increased	increase	VBN	I-VP	O
on	on	IN	B-PP	O
10/17/2005	10/17/2005	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Flomax	Flomax	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	RB	B-NP	O
qdaily	qdaily	RB	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

ASA	ASA	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	RB	B-ADVP	O
qdaily	qdaily	RB	B-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Levothyroxine	Levothyroxine	NN	B-NP	O
250	250	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
po	po	VBP	B-VP	O
qdaily	qdaily	RB	B-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Casodex	Casodex	NN	B-NP	O
and	and	CC	I-NP	O
lupron	lupron	NN	I-NP	O
qmonth	qmonth	NN	I-NP	O
for	for	IN	B-PP	O
hormonal	hormonal	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
of	of	IN	B-PP	O
prostate	prostate	NN	B-NP	O
cancer	cancer	NN	I-NP	O
SOCIAL	SOCIAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Lives	Live	VBZ	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
wife	wife	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
EtOH	EtOH	NN	I-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
smoking	smoking	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
P	P	NN	B-NP	B-protein
69	69	CD	I-NP	I-protein
;	;	:	O	O
BP	BP	NN	B-NP	O
168/80	168/80	CD	I-NP	O
;	;	:	O	O
O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
RA	RA	NN	B-NP	O
NAD	NAD	NN	I-NP	O
JVP	JVP	NN	I-NP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
given	give	VBN	B-NP	O
body	body	NN	I-NP	O
habits	habit	VBZ	B-VP	O
Bibasilar	Bibasilar	NNP	B-NP	O
crackles	crackle	VBZ	B-VP	O
RRR	RRR	NNP	B-NP	O
.	.	.	O	O

S1	S1	NN	B-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
normal	normal	JJ	I-NP	O
intensity	intensity	NN	I-NP	O
.	.	.	O	O

Grade	Grade	NN	B-NP	O
2/6	2/6	CD	I-NP	O
diamond-shaped	diamond-shaped	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
RUSB	RUSB	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
minimal	minimal	JJ	I-NP	O
radiation	radiation	NN	I-NP	O
.	.	.	O	O

+	+	SYM	B-NP	O
BS	BS	NN	I-NP	O
.	.	.	O	O

Obese	Obese	UH	B-INTJ	O
.	.	.	O	O

ND/NT	ND/NT	NN	B-NP	O
.	.	.	O	O

Trace	Trace	NN	B-NP	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADJP	O
in	in	IN	B-PP	O
lower	low	JJR	B-NP	O
extremities	extremity	NNS	I-NP	O
Alert	Alert	NN	I-NP	O
and	and	CC	I-NP	O
orientedx3	orientedx3	NN	I-NP	O
LABORATORY	LABORATORY	NN	I-NP	O
DATA	DATA	NN	I-NP	O
,	,	,	O	O
10/28	10/28	CD	B-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

WBC	WBC	NN	B-NP	B-protein
5.6	5.6	CD	I-NP	I-protein
-LRB-	-LRB-	:	O	O
N	N	NN	B-NP	O
63	63	CD	I-NP	O
,	,	,	O	O
L	L	NN	B-NP	B-protein
24	24	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
;	;	:	O	O
Hct	Hct	NN	B-NP	O
37.5	37.5	CD	I-NP	O
;	;	:	O	O
PLT	PLT	NN	B-NP	O
165	165	CD	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
1.0	1.0	CD	I-NP	O
;	;	:	O	O
PTT	PTT	NN	B-NP	B-protein
28	28	CD	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Na	Na	NN	B-NP	O
+	+	SYM	O	O
138	138	CD	B-NP	O
;	;	:	O	O
K	K	NN	B-NP	O
+	+	SYM	B-ADJP	O
4.0	4.0	CD	B-NP	O
;	;	:	O	O
Cl	Cl	NN	B-NP	O
-	-	HYPH	B-ADJP	O
101	101	CD	B-NP	O
;	;	:	O	O
CO2	CO2	NN	B-NP	O
27	27	CD	I-NP	O
;	;	:	O	O
BUN	BUN	NN	B-NP	O
18	18	CD	I-NP	O
;	;	:	O	O
creatinine	creatinine	NN	B-NP	O
1.0	1.0	CD	I-NP	O
;	;	:	O	O
glucose	glucose	NN	B-NP	O
141	141	CD	B-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Mg2	Mg2	NN	B-NP	O
+	+	SYM	O	O
2.2	2.2	CD	B-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
a.	a.	FW	I-NP	O
CK	CK	NN	I-NP	O
:	:	:	O	O
45.57	45.57	CD	B-NP	O
.58	.58	CD	I-NP	O
b.	b.	NN	I-NP	O
MB	MB	NN	I-NP	O
:	:	:	O	O
1.2.1.1.0.9	1.2.1.1.0.9	CD	B-NP	O
c.	c.	NN	I-NP	O
TROPONIN	TROPONIN	NN	I-NP	O
:	:	:	O	O
<	<	SYM	B-NP	O
0.1	0.1	CD	I-NP	O
.	.	.	O	O

<	<	SYM	O	O
0.1	0.1	CD	B-NP	O
.	.	.	O	O

<	<	SYM	O	O
0.1	0.1	CD	B-NP	O
RELEVANT	RELEVANT	NN	I-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
Sinus	Sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
rate	rate	NN	I-NP	B-protein
69	69	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

1st	1st	JJ	B-NP	O
degree	degree	NN	I-NP	O
AV	AV	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

QRS	QRS	NNS	B-NP	B-protein
widened	widen	VBD	B-VP	O
~	~	SYM	B-NP	O
100	100	CD	B-NP	O
msec	msec	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
.	.	.	O	O

Slightly	Slightly	RB	B-NP	O
prolonged	prolonged	JJ	I-NP	O
Qt	Qt	NNP	I-NP	O
at	at	IN	B-PP	O
471	471	CD	B-NP	O
msec	msec	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

6/18	6/18	CD	B-NP	O
CARDIAC	CARDIAC	NN	I-NP	O
MRI	MRI	NN	I-NP	O
:	:	:	O	O
a.	a.	LS	B-LST	O
Concentric	Concentric	NNP	B-NP	O
LVH	LVH	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LVEDV	LVEDV	NNP	I-NP	O
133	133	CD	I-NP	O
mL	mL	NN	I-NP	O
,	,	,	O	O
LVESV	LVESV	NN	B-NP	O
49	49	CD	I-NP	O
mL	mL	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	I-NP	O
normal	normal	JJ	I-NP	O
global	global	JJ	I-NP	O
LV	LV	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LVEF	LVEF	NN	I-NP	O
~	~	NN	I-NP	O
63	63	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
b.	b.	NN	I-NP	O
Small	Small	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
distal	distal	JJ	B-NP	O
anterior	anterior	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
c.	c.	NN	I-NP	O
Basal	Basal	JJ	B-ADJP	O
to	to	TO	B-VP	O
mid	mid	VB	I-VP	O
patchy	patchy	JJ	B-NP	O
septal	septal	JJ	I-NP	O
subendocardial	subendocardial	JJ	I-NP	O
delayed	delay	VBN	I-NP	O
enhancement	enhancement	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
fibrosis	fibrosis	NN	I-NP	O
or	or	CC	I-NP	O
scar	scar	NN	I-NP	O
d.	d.	NN	I-NP	O
On	On	IN	B-PP	O
first	first	JJ	B-NP	O
pass	pass	NN	I-NP	O
perfusion	perfusion	NN	I-NP	O
imaging	imaging	NN	I-NP	O
,	,	,	O	O
mid	mid	JJ	B-NP	O
anterior	anterior	JJ	I-NP	O
and	and	CC	I-NP	O
basal	basal	JJ	I-NP	O
to	to	TO	B-VP	O
mid	mid	VB	I-VP	O
inferior	inferior	JJ	B-NP	O
and	and	CC	I-NP	O
inferolateral	inferolateral	JJ	I-NP	O
walls	wall	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
moderate	moderate	JJ	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
segmental	segmental	JJ	B-NP	O
reversibility	reversibility	NN	I-NP	O
c/w	c/w	NN	I-NP	O
inducible	inducible	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
LAD/diagonal	LAD/diagonal	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
RCA	RCA	NN	I-NP	O
territories	territory	NNS	I-NP	O
.	.	.	O	O

e.	e.	LS	B-NP	O
Normal	Normal	JJ	I-NP	O
RV	RV	NN	I-NP	O
size	size	NN	I-NP	O
and	and	CC	I-NP	O
RV	RV	NN	I-NP	O
global	global	JJ	I-NP	O
and	and	CC	I-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
f.	f.	NN	I-NP	O
Prosthetic	Prosthetic	JJ	I-NP	O
valve	valve	NN	I-NP	O
in	in	IN	B-PP	O
aortic	aortic	JJ	B-NP	B-protein
position	position	NN	I-NP	I-protein
seen	see	VBN	B-VP	I-protein
4	4	CD	B-NP	I-protein
.	.	.	O	O

9/1	9/1	CD	B-NP	O
ECHO	ECHO	NN	I-NP	O
:	:	:	O	O
Left	Left	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LV	LV	NN	I-NP	O
posterior	posterior	JJ	I-NP	O
wall	wall	NN	I-NP	O
thickness	thickness	NN	I-NP	O
12	12	CD	I-NP	O
mm	mm	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
preserved	preserve	VBN	B-VP	O
systolic	systolic	JJ	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

Estimated	Estimate	VBN	B-NP	O
EF	EF	NN	I-NP	O
~	~	NN	I-NP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
no	no	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
RWMA	RWMA	NN	I-NP	O
.	.	.	O	O

LVDD	LVDD	NN	B-NP	O
4.2	4.2	CD	I-NP	O
cm	cm	NN	I-NP	O
/	/	SYM	B-NP	O
LVSD	LVSD	NN	B-NP	O
2.9	2.9	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
right	right	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
size	size	NN	I-NP	O
and	and	CC	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
AI	AI	NN	I-NP	O
.	.	.	O	O

Mild	Mild	NNP	B-NP	O
MR.	MR.	NNP	I-NP	O
Mild	Mild	NNP	I-NP	O
TR	TR	NNP	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
artery	artery	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
pressures	pressure	NNS	I-NP	O
.	.	.	O	O

OVERALL	OVERALL	NN	B-NP	O
ASSESSMENT	ASSESSMENT	NN	I-NP	O
:	:	:	O	O
81M	81M	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
h/o	h/o	NN	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
3-vessel	3-vessel	NN	I-NP	O
CABG	CABG	NN	I-NP	O
and	and	CC	I-NP	O
PCIx4	PCIx4	NN	I-NP	B-protein
admitted	admit	VBD	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
2	2	CD	I-NP	O
month	month	NN	I-NP	O
h/o	h/o	NN	I-NP	O
increasingly	increasingly	RB	B-NP	O
frequent	frequent	JJ	I-NP	O
exertional	exertional	JJ	I-NP	O
CP	CP	NN	I-NP	B-DNA
and	and	CC	O	O
abnormal	abnormal	JJ	B-NP	O
adenosine-MRI	adenosine-MRI	NN	I-NP	O
.	.	.	O	O

LHC	LHC	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
3VD	3VD	NN	I-NP	O
and	and	CC	O	O
successful	successful	JJ	B-NP	O
PCI	PCI	NN	I-NP	O
to	to	TO	B-PP	O
SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
Marg2	Marg2	NN	B-NP	B-protein
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CARDS	CARDS	NNP	B-NP	O
ISCHEMIA	ISCHEMIA	NNP	I-NP	O
:	:	:	O	O
Chronic	Chronic	NNP	B-NP	O
stable	stable	JJ	I-NP	O
angina	angina	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
negative	negative	JJ	I-NP	O
enzymesx3	enzymesx3	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
abnormal	abnormal	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
MRI	MRI	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
progression	progression	NN	B-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
.	.	.	O	O

6/13/2006	6/13/2006	CD	B-NP	O
LHC	LHC	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Right	Right	RB	B-NP	O
dominant	dominant	JJ	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
LM	LM	NN	I-NP	B-protein
lesions	lesion	NNS	I-NP	I-protein
3	3	CD	B-NP	I-protein
.	.	.	O	O

LAD	LAD	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	I-NP	O
proximal	proximal	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
discrete	discrete	JJ	I-NP	O
1005	1005	CD	I-NP	O
lesion	lesion	NN	I-NP	O
after	after	IN	B-PP	O
D1	D1	NN	B-NP	O
origin	origin	NN	I-NP	O
.	.	.	O	O

D1	D1	NN	B-NP	O
widely	widely	RB	I-NP	O
patent	patent	NN	I-NP	O
including	include	VBG	B-PP	O
prior	prior	JJ	B-NP	O
stent	stent	NN	I-NP	O
.	.	.	O	O

LAD	LAD	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
mid	mid	JJ	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
a	a	DT	B-NP	O
discrete	discrete	JJ	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Cx	Cx	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	I-NP	O
proximal	proximal	JJ	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
discrete	discrete	JJ	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

RCA	RCA	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	I-NP	O
proximal	proximal	JJ	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
discrete	discrete	JJ	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

LIMA	LIMA	NN	B-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
patent	patent	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
distal	distal	JJ	B-NP	O
LAD	LAD	NN	I-NP	O
occluded	occlude	VBD	B-VP	O
-LRB-	-LRB-	NN	B-NP	B-protein
small	small	JJ	I-NP	I-protein
vessel	vessel	NN	I-NP	I-protein
disease	disease	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
Marg2	Marg2	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
distal	distal	JJ	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
a	a	DT	B-NP	O
tubular	tubular	JJ	I-NP	B-protein
70	70	CD	I-NP	I-protein
%	%	NN	I-NP	I-protein
lesion	lesion	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
Right	Right	NN	B-NP	O
PDA	PDA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ostial	ostial	JJ	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
a	a	DT	B-NP	O
discrete	discrete	JJ	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Collateral	Collateral	JJ	B-NP	O
flow	flow	NN	I-NP	O
from	from	IN	B-PP	O
Marg2	Marg2	NN	B-NP	B-protein
to	to	TO	B-PP	O
right	right	JJ	B-NP	B-protein
PDA	PDA	NN	I-NP	I-protein
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

PCI	PCI	NN	B-NP	O
:	:	:	O	O
SVG	SVG	NN	B-NP	O
TO	TO	TO	B-VP	O
MARG2	MARG2	NN	I-VP	B-protein
TO	TO	TO	B-PP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
W	W	NN	I-NP	O
/	/	SYM	B-VP	O
A	A	NN	B-NP	O
3.5	3.5	CD	I-NP	O
mm	mm	NN	I-NP	O
CYPHER	CYPHER	NN	I-NP	O
POSTDILATED	POSTDILATED	VBD	B-VP	O
TO	TO	TO	B-PP	O
4.0	4.0	CD	B-NP	O
mm	mm	NN	I-NP	O
W	W	NN	I-NP	O
/	/	SYM	B-NP	O
GOOD	GOOD	NN	I-NP	O
RESULT	RESULT	NN	I-NP	O
.	.	.	O	O

Received	Receive	VBN	B-NP	O
ASA	ASA	NN	I-NP	O
and	and	CC	I-NP	O
lipitor	lipitor	NN	I-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

Briefly	Briefly	RB	B-ADVP	O
on	on	IN	B-PP	O
integrillin	integrillin	NN	B-NP	O
gtt	gtt	NN	I-NP	O
following	follow	VBG	B-PP	O
catheterization	catheterization	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
discontinued	discontinue	VBD	B-VP	O
following	follow	VBG	I-VP	O
a	a	DT	B-NP	O
retroperitoneal	retroperitoneal	JJ	I-NP	O
bleed	bleed	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
see	see	VBP	B-VP	O
below	below	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

Had	Have	VBD	B-VP	O
recurrent	recurrent	JJ	B-NP	O
CP	CP	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
ambulation	ambulation	NN	I-NP	O
on	on	IN	B-PP	O
6/16	6/16	CD	B-NP	O
-	-	HYPH	I-NP	O
isordil	isordil	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
AM	AM	NN	I-NP	O
,	,	,	O	O
restarted	restart	VBD	B-VP	O
in	in	IN	B-PP	O
PM	PM	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Discharged	Discharge	VBN	B-VP	O
on	on	IN	B-PP	O
isrodil	isrodil	NN	B-NP	O
and	and	CC	I-NP	O
toprol	toprol	NN	I-NP	O
XL	XL	NN	I-NP	O
.	.	.	O	O

Should	Should	MD	B-VP	O
be	be	VB	I-VP	O
converted	convert	VBN	I-VP	O
to	to	TO	B-VP	O
imdur	imdur	VB	I-VP	O
and	and	CC	O	O
uptitrated	uptitrate	VBD	B-VP	O
as	as	IN	B-PP	O
necessary	necessary	JJ	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

CARDS	CARDS	NN	B-NP	O
PUMP	PUMP	NN	I-NP	O
:	:	:	O	O
Hypotensive	Hypotensive	JJ	B-ADJP	O
on	on	IN	B-PP	O
10/27	10/27	CD	B-NP	O
likely	likely	JJ	I-NP	O
2/2	2/2	CD	I-NP	O
volume	volume	NN	I-NP	O
depletion	depletion	NN	I-NP	O
.	.	.	O	O

Was	Be	VBD	B-VP	O
orthostatic	orthostatic	JJ	B-ADJP	O
again	again	RB	B-ADVP	O
on	on	IN	B-PP	O
10/5	10/5	CD	B-NP	O
AM	AM	NN	I-NP	O
following	follow	VBG	B-PP	O
lasix	lasix	NN	B-NP	O
and	and	CC	I-NP	O
flomax	flomax	NN	I-NP	O
.	.	.	O	O

Again	Again	RB	B-ADVP	O
on	on	IN	B-PP	O
6/16	6/16	CD	B-NP	O
developed	develop	VBD	B-VP	O
orthostatic	orthostatic	JJ	B-NP	O
hypotension	hypotension	NN	I-NP	O
after	after	IN	B-PP	O
sustaining	sustain	VBG	B-VP	O
blood	blood	NN	B-NP	O
loss	loss	NN	I-NP	O
from	from	IN	B-PP	O
retroperitoneal	retroperitoneal	JJ	B-NP	O
blood	blood	NN	I-NP	O
;	;	:	O	O
not	not	RB	B-ADJP	O
symptomatic	symptomatic	JJ	I-ADJP	O
on	on	IN	B-PP	O
4/30	4/30	CD	B-NP	O
Encouraged	Encouraged	JJ	I-NP	O
po	po	NN	I-NP	O
intake	intake	NN	I-NP	O
and	and	CC	O	O
held	hold	VBD	B-VP	O
BP	BP	NN	B-NP	O
medications	medication	NNS	I-NP	O
on	on	IN	B-PP	O
6/16	6/16	CD	B-NP	O
AM	AM	NN	I-NP	O
.	.	.	O	O

Recommend	Recommend	VB	B-VP	O
that	that	DT	B-NP	O
flomax	flomax	NN	I-NP	O
be	be	VB	B-VP	O
held	hold	VBN	I-VP	O
indefinitely	indefinitely	RB	B-ADVP	O
;	;	:	O	O
have	have	VBP	B-VP	O
restarted	restart	VBN	I-VP	O
lasix	lasix	CD	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	RB	B-ADVP	O
qdaily	qdaily	RB	I-ADVP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
should	should	MD	B-VP	O
restart	restart	VB	I-VP	O
on	on	IN	B-PP	O
6/16	6/16	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

CARDS	CARDS	NNP	B-NP	O
RHYTHM	RHYTHM	NNP	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
cath	cath	NN	I-NP	O
.	.	.	O	O

c/b	c/b	NN	B-NP	O
retroperitoneal	retroperitoneal	JJ	I-NP	O
bleeding	bleed	VBG	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
Hct	Hct	NN	I-NP	O
nadir	nadir	NN	I-NP	O
to	to	TO	B-PP	O
30.8	30.8	CD	B-NP	O
on	on	IN	B-PP	O
6/16	6/16	CD	B-NP	O
AM	AM	NN	I-NP	O
.	.	.	O	O

Hct	Hct	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

ENDO	ENDO	NNP	B-NP	O
a.	a.	FW	I-NP	O
Home	Home	NNP	I-NP	O
levoxyl	levoxyl	NN	I-NP	O
250	250	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
po	po	VBP	B-VP	O
qdaily	qdaily	RB	B-ADVP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
1.862	1.862	CD	I-NP	O
and	and	CC	O	O
WNL	WNL	NNP	B-NP	O
.	.	.	O	O

b.	b.	LS	B-NP	O
Held	Held	NNP	I-NP	O
home	home	NN	I-NP	O
glyburide	glyburide	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
lantus	lantus	NN	B-NP	O
10	10	CD	I-NP	O
U	U	NN	I-NP	O
sc	sc	NN	I-NP	O
qhs	qh	NNS	I-NP	O
and	and	CC	O	O
RISS	RISS	NN	B-NP	B-protein
while	while	IN	B-SBAR	O
hospitalized	hospitalize	VBN	B-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

PPX	PPX	NN	B-NP	B-protein
:	:	:	O	O
PPI	PPI	NN	B-NP	B-protein
and	and	CC	I-NP	O
heparin	heparin	NN	I-NP	B-protein
sc	sc	NN	I-NP	I-protein
tid	tid	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-VP	I-protein
no	no	DT	B-NP	O
lovenox	lovenox	NN	I-NP	O
in	in	IN	B-PP	O
anticipation	anticipation	NN	B-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
cath	cath	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

CODE	CODE	NN	B-NP	O
:	:	:	O	O
FULL	FULL	NN	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
take	take	VB	B-VP	O
all	all	DT	B-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
attend	attend	VB	B-VP	O
follow-up	follow-up	JJ	B-NP	O
appointments	appointment	NNS	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
seek	seek	VB	I-VP	O
medical	medical	JJ	B-NP	O
attention	attention	NN	I-NP	O
again	again	RB	B-ADVP	O
immediately	immediately	RB	B-ADVP	O
if	if	IN	B-SBAR	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
returns	return	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Please	Please	NNP	I-NP	I-protein
restart	restart	VB	B-VP	O
lasix	lasix	CD	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	RB	B-ADVP	O
qdaily	qdaily	RB	I-ADVP	O
on	on	IN	B-PP	O
5/29	5/29	CD	B-NP	O
Have	Have	VBP	B-VP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
reeval	reeval	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
TIXIER	TIXIER	NN	B-NP	O
,	,	,	O	O
FRANCES	FRANCES	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WZ70	WZ70	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/16/06	10/16/06	CD	I-NP	O
@	@	SYM	B-NP	O
02	02	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

